From Patient Cells to Patient Care: Organ-on-a-Chip Research Helps Deliver New Hope for Children with Heart Disease
Article written by Jasleen Dhaliwal and Jennifer Doucet From engineered heart tissues to real-world patient outcomes, Canadian researchers have shown how organ-on-a-chip technology can accelerate the path from discovery to treatment. A recent Phase 3 trial in adolescents with hypertrophic cardiomyopathy confirmed the effectiveness of mavacamten, building on earlier studies that used patient-specific cardiac tissues…
